Chang AY - Search Results

1

Aclacinomycin A and etoposide (VP-16-213): an effective regimen in previously treated patients with refractory acute myelogenous leukemia.

Rowe JM, Chang AY, Bennett JM. Rowe JM, et al. Among authors: chang ay. Blood. 1988 Apr;71(4):992-6. Blood. 1988. PMID: 3162695 Free article.

2

A study of aminoglutethemide and hydrocortisone in patients with advanced and refractory prostate carcinoma.

Chang AY, Bennett JM, Pandya KJ, Asbury R, McCune C. Chang AY, et al. Am J Clin Oncol. 1989 Aug;12(4):358-60. doi: 10.1097/00000421-198908000-00017. Am J Clin Oncol. 1989. PMID: 2474242

3

Treatment of refractory acute leukaemia with aclacinomycin A.

Rowe JM, Chang AY, Bennett JM. Rowe JM, et al. Among authors: chang ay. Bone Marrow Transplant. 1989 Dec;4 Suppl 3:47-8. Bone Marrow Transplant. 1989. PMID: 2627607 No abstract available.

4

Refractory acute lymphocytic leukemia: response to aclacinomycin A and VP-16-213.

Rowe JM, Chang AY, Bennett JM. Rowe JM, et al. Among authors: chang ay. Hematol Oncol. 1989 Nov-Dec;7(6):405-10. doi: 10.1002/hon.2900070603. Hematol Oncol. 1989. PMID: 2807178

5

Phase I clinical and pharmacokinetic study of diethyldithiocarbamate as a chemoprotector from toxic effects of cisplatin.

Qazi R, Chang AY, Borch RF, Montine T, Dedon P, Loughner J, Bennett JM. Qazi R, et al. Among authors: chang ay. J Natl Cancer Inst. 1988 Nov 16;80(18):1486-8. doi: 10.1093/jnci/80.18.1486. J Natl Cancer Inst. 1988. PMID: 2846857

6

5-Fluorouracil and high-dose folic acid treatment for metastatic colon cancer.

Asbury RF, Boros L, Brower M, Woll J, Chang A, Bennett J. Asbury RF, et al. Am J Clin Oncol. 1987 Feb;10(1):47-9. doi: 10.1097/00000421-198702000-00011. Am J Clin Oncol. 1987. PMID: 3825992

7

A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy.

Tepler I, Elias L, Smith JW 2nd, Hussein M, Rosen G, Chang AY, Moore JO, Gordon MS, Kuca B, Beach KJ, Loewy JW, Garnick MB, Kaye JA. Tepler I, et al. Among authors: chang ay. Blood. 1996 May 1;87(9):3607-14. Blood. 1996. PMID: 8611684 Free article. Clinical Trial.

8

Ifosfamide, carboplatin and etoposide (ICE) in metastatic and refractory breast cancer.

Chang AY, Hui L, Asbury R, Boros L, Garrow G, Rubins J. Chang AY, et al. Cancer Chemother Pharmacol. 1999;44 Suppl:S26-8. doi: 10.1007/s002800051113. Cancer Chemother Pharmacol. 1999. PMID: 10602907 Clinical Trial.

9

Ifosfamide/carboplatin/etoposide chemotherapy in patients with metastatic non-small cell lung cancer.

Chang AY, Asbury RF, Boros L, Garrow GC, Hsieh S. Chang AY, et al. Semin Oncol. 1995 Jun;22(3 Suppl 7):9-12. Semin Oncol. 1995. PMID: 7610399 Clinical Trial.

10

Paclitaxel by 3-hour infusion followed by 96-hour infusion on failure in patients with refractory malignant disease.

Chang AY, Boros L, Garrow G, Asbury R. Chang AY, et al. Semin Oncol. 1995 Jun;22(3 Suppl 6):124-7. Semin Oncol. 1995. PMID: 7597429 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

602 results

Search Page

Filters